Clinical Trial Search

Primary: Percentage of Participants Who Have Hypotensive Syncope or Near Syncope With SBP Less Than or Equal to 70 mmHG During Tilt Test — 32; 27; 33; 35 Participants — p=0.521

Primary: Syncope Recurrence Rate

Primary: Number of Participants Who Become Syncopal Associated With Diagnostic Criteria of Hypotension and Bradycardia — 19; 10 Participants

Primary: Number of Participants at End of Study — 20; 24 Participants

Primary: The Primary Outcome Measure Will be the Recurrence of Syncope in Follow up Period. — 42; 54 Participants

Primary: Sensitivity of the Syncope Prediction Algorithm — 81; 2 Participants

Primary: Patients With Recurrence of Syncopal Episode — 10; 34 Participants — p=<0.001

Primary: Number of Adolescents With Presyncope or Syncope After Vaccination in the Intervention and Usual Care Groups. — 80; 59 Participants — p=0.0249

Primary: Device Unable to Monitor Due to ECG Noise — 1.5 percentage of time worn

Primary: Number of Patients That Adhere to the 2009 Syncope Guidelines (ESC2009) — 233 Participants

Primary: Combined Endpoint Defined as First Occurrence Among the Following Events 1)Syncope Episode of Any Origin; 2)Presyncopal Episode With Documented Cardioinhibitory Origin…

Primary: The Change in Composite Autonomic Symptom Score (COMPASS-31) — -5.40; -5.94 score on a scale

Primary: Syncope Recurrence Rate — 57; 25 percentage of participants — p=0.04

Primary: Heart Rate [Bpm] at Specific Time-points During Head-up Tilt Test (HUTT) Examination — 70; 88; 105; 95 beats per minute

Primary: Average Daily Use of Rescue Medications for Exacerbation of Nausea/Vomiting. — 1.186; 0.551; 0.754; 0.447 medications/day

Primary: Number of Ambulatory Patch Monitor Participants Having Significant Symptomatic Arrhythmia — 9 Participants

Primary: Change in Seizure Frequency or Duration Via a Routine Seizure History Used in Clinical Practice.

Primary: Assessing Heart Rate During the Supine and Modified VM and Assessing Heart Rate While Using the VAD and Manometer — 33.6; 25.9; 28.7; 30.8 beat per minute — p=<0.001

Primary: Blood Pressure (Systolic) — 156; 158; 179; 148 mm Hg

Primary: Change in Heart Rate — 17.0; 13.1 beats per minute

Primary: Hemodynamics as Characterized by Vasoactive Inotrope Score (VIS) — 11; 11.3 units

Primary: Systemic Vascular Resistance (SVR) — 480; 410; 588; 420 dyne*sec/cm^5

Primary: C-peptide Levels After Oral Glucose Tolerance Test — 40.6; 23.2 pg/mL

Primary: Brain Activity Changes (Average Differences in Beta Weights From Significantly Activated Regions: Post-stimulation Minus Pre-stimulation) Evaluated Using Functional…

Primary: Changes in Vasopressin Levels During Pneumoperitoneum and Elevated PEEP — 2.37; 45.48; 54.75; 31.57 pg/ml — p=<0.0001

Primary: Time to Hemostasis (TTH) — 5.87 minutes

Primary: Change in the OHQ (Orthostatic Hypotension Questionnaire) Composite Score — 4.61; 4.17; 3.35; 3.5 Score on a scale

Primary: Level of Interleukin-6 (IL6) — 0.88; 0.84; 1.77; 2.11 pg/ml

Primary: Number of Participants With Return of Spontaneous Circulation — 100; 86 participants

Primary: Number of Ventricular Ectopic Beats Recorded During Exercise (and Recovery) — 46; 0 number of ventricular beats